AstraZeneca Debate
Full Debate: Read Full DebateDepartment: Department for Science, Innovation & Technology
Esther McVey
Main Page: Esther McVey (Conservative - Tatton)Department Debates - View all Esther McVey's debates with the Department for Science, Innovation & Technology
(1 day, 14 hours ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Urgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Chris Bryant
That is the cleverest bid for finance that I have ever heard, so my hon. Friend gets an award for that. She is right that we stand ready at any point to assist key investments of this nature, especially in the life sciences sector. The difference between the amount of money that was theoretically made available by the previous Government and the amount that we were prepared to put forward was remarkably small. The issue is how to ensure that similar investments get over the line. Someone from the Department will meet Steve Rotheram.
Esther McVey (Tatton) (Con)
How does losing £450 million of investment on Merseyside and into the wider north-west area equate with the Chancellor’s stated priority of economic growth?
Chris Bryant
The right hon. Lady puts it in a particular way, but it is not a way that is consonant with the facts. The fact is that this deal had not been signed or got over the line by the previous Government, who, as I have said, would quite often announce things and not actually deliver in the end. In spring 2024, the then Chancellor made it very clear in the documents that accompanied the Budget that all of this was contingent—his words, not mine—on due diligence. The then Government had not yet done the due diligence.